Tag: drug discovery
Merck confirms drug design from Stanford’s 37,000-agent virtual biotech
Stanford's virtual biotech of 37,000 AI agents designed a lung cancer drug that Merck later validated.
OpenAI bets on academia with free frontier AI for 100,000 scientists
OpenAI will give up to 100,000 academic researchers free access to frontier models, including 75-plus life-science tools for genomics and…
AI-focused venture firm Dimension restocks with $800M third fund
AI-biotech venture firm Dimension closes $800M third fund to invest at the intersection of computing and life sciences.
NIH commits to $5B Genesis Mission for biomedical AI research
HHS commits NIH resources to Trump's $5B Genesis Mission, targeting chronic disease, pediatric cancer, and drug discovery through AI.
Doudna Lab uses AI to design novel gene-editing enzymes from scratch
Nobel laureate Jennifer Doudna's team uses inverse protein folding AI to create never-before-seen genome editing enzymes.
Insilico and Bora Pharma bring generative AI to drug manufacturing
The alliance extends Insilico's PandaOmics and Chemistry42 platforms into pharmaceutical manufacturing for the first time, targeting a $168B CDMO industry.
How Machine Learning Is Reshaping Pharmaceutical R&D
AI is reshaping pharmaceutical R&D from target identification through clinical trial optimization, compressing drug discovery timelines and unlocking therapeutic targets…
Pharma AI Alliance Expands: Owkin and AstraZeneca Deploy New Drug Discovery Models
Owkin and AstraZeneca are expanding their AI collaboration to develop new drug discovery models using federated learning, a technique that…